HIGHLIGHTS
- who: Elif Engin from the University of Mississippi Medical Center, United States have published the research work: GABAA receptor subtypes and benzodiazepine use, misuse, and abuse, in the Journal: (JOURNAL)
- what: Aside from continued need for therapeutic relief, withdrawal symptoms are the primary reason for long-term BDZ use.
- how: Based on the above-noted differences in GABAAR expression in different species it is important to reemphasize here is that while all of the two-bottle choice CPP and ICSS studies reviewed above were conducted in rodents all of the self-administration studies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.